Wilson is a proud military veteran having served as a fleet marine force qualified officer and US Navy flight surgeon. Post-military, he has been working as a practicing physician, board-certified in internal medicine, infectious diseases, and critical care medicine through the American Board of Internal Medicine and the American Osteopathic Board of Internal Medicine. He is also certified in military tropical medicine and by the American Society of Tropical Medicine & Hygiene. Wilson also serves as an associate professor of Internal Medicine and chair of Clinical Sciences at Niazee College of Osteopathic Medicine—where he's helping build the curriculum for a brand-new osteopathic medical school in the Chicagoland area. He does all this while keeping up with his young children.
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Histoplasma, Blastomyces, and Coccidioides remain underrecognized causes of community-acquired pneumonia, particularly when clinical presentation mimics bacterial disease. Knowing where to look and when reshapes the diagnostic and therapeutic approach.
The FDA recently approved intravenous fosfomycin (Contepo), which is a new option for adults with complicated urinary tract infections, including those caused by resistant Gram-negative pathogens. Here is an overview of the therapeutic including its mechanism of action, data, availability, and prospective costs.
Disease management now centers on more precise, context-driven diagnostics, restrained empiric antifungal use, echinocandin-focused therapy, and risk-based ophthalmologic evaluation aligned across global and US guidelines.
Although COVID-19 has receded quite a bit from the minds of many, it still remains a virus that can present serious morbidity and mortality. Here is a review of clinical treatment strategies by an intensivist when seeing patients with severe COVID-19.
The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.
February 5th 2026
September 9th 2026
